Can we predict septic shock in patients with hospital-acquired pneumonia?

Critical Care

Volumn 9, Issue 6, 2005, Pages 640-641

  de Lange, Dylan W ^a   Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ANTIMICROBIAL THERAPY; DETERIORATION; EARLY DIAGNOSIS; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NOTE; PATIENT CARE; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPTIC SHOCK; VENTILATOR ASSOCIATED PNEUMONIA; CONTROLLED STUDY; DISEASE COURSE; RISK REDUCTION;

BIOLOGICAL MARKERS; CRITICAL CARE; CROSS INFECTION; DISEASE PROGRESSION; HUMANS; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SHOCK, SEPTIC;

EID: 31744449381     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc3919     Document Type: Note

References (4)

1. von Dossow V, Rotard K, Redlich U, Hein OV, Spies CD: Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Crit Care 2005, 9:R662-R669.
2. American Thoracic Society; Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
3. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
4. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl JL, Sollet JP, Tenaillon A: Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000, 132:621-630.